SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (2000)8/14/1997 2:45:00 AM
From: Vector1   of 9719
 
Andrew, congrats on 2000. You win warrants to buy 1000 shares of Autoimmune at $20 per share. Seriously VISX was recently approved for astigmatism. I spoke with an analyst today on VISX and he had no explaination for the stock decline. He noted the accelleration in royalties and the fact that Laser Vision Centers(I think thats the name) was reporting a 90% increase in proceedures in the second quarter. This will show up in VISX's rev in the 3rd quarter as there is 60 day delay as the revs go through Pillar Point. I have a feeling that an acquisition is in the works. The company has a hoard of cash and earlier in the year they were using it to buy back stock. Obviously they have not been buying in stock recently notwithstanding that the q has been filed and the company is not in a blackout period. If they are in serious acquisition discussions they could not go into the market and buy their own stock. I wonder who they are looking at and I hope it is not a stock deal at these depressed levels.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News